Drinking more than one soda daily may increase liver disease risk by 50% to 60%. Replacing soda with water could reduce liver ...

A new study finds one can of diet soda may increase NAFLD risk by 60%, while water reduces it, challenging diet drink safety.

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat ...

Researchers released a study suggesting both sugary drinks and diet sodas are associated with a higher risk of consumers ...

A new European study finds both sugary and diet sodas raise risk of metabolic liver disease—even at modest intake levels.

Two everyday medications, pemafibrate and telmisartan, could offer a safer, faster route to treating fatty liver disease.

New research found that less than one can of soda a day can raise your risk of developing a fatty liver by up to 60%.

A Swedish team created a test that predicts severe liver disease years ahead. It could help doctors detect risk early using routine blood data. A recent study from Karolinska Institutet, published in ...

Novo Nordisk A/S agreed to buy Akero Therapeutics Inc. for as much as $5.2 billion to expand its portfolio in a type of liver ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a silent liver disease that is caused by fat buildup, inflammation ...

The new term metabolic dysfunction-associated steatotic liver disease makes sense mechanistically and clinically, but more ...

A “modest intake” of fizzy drinks is linked to a 60% higher risk of liver disease, new evidence has indicated. Researchers ...